CN Patent

CN120077037A — 双重raf/mek抑制剂的固体形式

Assigned to Verastem Inc · Expires 2025-05-30 · 1y expired

What this patent protects

本文描述了双重RAF/MEK抑制剂的固体形式、其药物组合物、其口服剂型和治疗癌症的方法。本文还提供制备双重RAF/MEK抑制剂的固体形式和其药物组合物和口服剂型的方法。

USPTO Abstract

本文描述了双重RAF/MEK抑制剂的固体形式、其药物组合物、其口服剂型和治疗癌症的方法。本文还提供制备双重RAF/MEK抑制剂的固体形式和其药物组合物和口服剂型的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN120077037A
Jurisdiction: CN
Classification: —
Expires: 2025-05-30
Drug substance claim: No
Drug product claim: No
Assignee: Verastem Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.